Background: The term ‘posttraumatic embitterment disorder’ (PTED) was recently introduced to describe a subtype of adjustment disorders, characterized by prolonged embitterment, severe additional psychopathological symptoms and great impairment in most areas of life in reaction to a severe negative but not life threatening life event. The aim of this study is an empirical description and validation of the clinical concept of PTED, by comparing clinically defined PTED patients with patients suffering from other mental disorders on measures of posttraumatic stress and psychopathological distress. Methods: Fifty inpatients, suffering from PTED according to previously defined clinical diagnostic criteria, were compared with another 50 patients, matched by age and gender, who did not meet clinical criteria for PTED but for other mental disorders. Psychiatric diagnoses were assessed by the Mini International Neuropsychiatric Interview. Self-report measures included the Bern Embitterment Scale, the Impact of Event Scale, the PTED Self-Rating Scale and the SCL-90. Results: According to the Mini International Neuropsychiatric Interview both groups fulfilled the criteria for many disorders with a significantly higher occurrence of major depression and chronic adjustment disorder but less generalized anxiety disorder lifetime in PTED patients. Patients with PTED scored significantly higher on the global scores and on most subdimensions of the SCL-90, the Impact of Event Scale, the Bern Embitterment Scale and the PTED Self-Rating Scale. Conclusions: Clear differences were found between PTED patients and patients with other mental disorders in regard to the quality and intensity of psychopathological as well as posttraumatic stress symptoms. PTED can help further subclassify and specify adjustment and reactive disorders.

1.
WHO: International Statistical Classification of Diseases and Related Health Problems, rev 10. Geneva, WHO, 1992.
2.
APA: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
3.
Casey P, Dorwick C, Wilkinson G: Adjustment disorders: fault line in the psychiatric glossary. Br J Psychiatry 2001;179:479–481.
4.
Van der Kolk BA, Herron N, Hostetler A: The history of trauma in psychiatry. Psychiatr Clin North Am 1994;17:583–600.
5.
O’Brien LS (ed): Traumatic Events and Mental Health. Cambridge, Cambridge University Press, 1998.
6.
Amiel-Lebigre F, Kovess V, Labarte S, Chevalier A: Symptom distress and frequency of life events. Soc Psychiatry Psychiatr Epidemiol 1995;33:263–268.
7.
Simon GE: Long-term prognosis of depression in primary care. Bull World Health Organ 2000;78:439–445.
8.
Andreasen NC, Wasek P: Adjustment disorders in adolescents. Arch Gen Psychiatry 1980;37:1166–1170.
9.
Fabrega H, Mezzich JE, Mezzich AC: Adjustment disorder as a marginal or transitional illness category in DSM-III. Arch Gen Psychiatry 1987;44:567–572.
10.
Snyder S, Strain JJ, Wolf D: Differentiating major depression from adjustment disorder with depressed mood in the medical setting. Gen Hosp Psychiatry 1990;12:159–165.
11.
Bronisch T, Hecht H: Validity of adjustment disorder: comparison with major depression. J Affect Disord 1989;17:229–236.
12.
Bronisch T: Adjustment reactions: a long-term prospective and retrospective follow-up of former patients in a crisis intervention ward. Acta Psychiat Scand 1991;84:86–93.
13.
Pollock D: Structured ambiguity and the definition of psychiatric illness: adjustment disorder among medical inpatients. Soc Sci Med 1992;35:25–35.
14.
Despland JN, Monod L, Ferrero F: Clinical relevance of adjustment disorder in DSM-III-R and DSM-IV. Compr Psychiatry 1995;36:454–460.
15.
Greenberg WM, Rosenfeld DN, Ortega EA: Adjustment disorder as an admission diagnosis. Am J Psychiatry 1995;152:459–461.
16.
Jones R, Yates WR, Williams S, Zhou M, Hardman L: Outcome for adjustment disorder with depressed mood: comparison with other mood disorders. J Affect Disord 1999;55:55–61.
17.
Linden M: The Posttraumatic embitterment disorder. Psychother Psychosom 2003;72:195–202.
18.
Marshall RD, Spitzer R, Liebowitz MR: Review and critique of the new DSM-IV diagnosis of acute stress disorder. Am J Psychiatry 1999;156:1677–1685.
19.
Davidson JRT, Foa EB, Blank AS, et al: Posttraumatic stress disorder; in Widiger TA, Frances AJ, Pincus HA, et al (eds): DSM-IV Sourcebook, vol 2. Washington, American Psychiatric Press, 1996, pp 577–606.
20.
Linden M, Schippan B, Baumann K, Spielberg R: Die posttraumatische Verbitterungsstörung (PTED): Abgrenzung einer spezifischen Form der Anpassungsstörungen. Nervenarzt 2003;75:51–57.
21.
McFarlane AC: Avoidance and intrusion in posttraumatic stress disorder. J Nerv Ment Dis 1992;180:439–445.
22.
Linden M, Baumann K, Rotter M, Schippan B: The psychopathology of posttraumatic embitterment disorders. Psychopathology 2007;40:159–165.
23.
Sheehan DV, Lecrubier Y, Sheehan KH, et al: The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59:22–33.
24.
Franke G: SCL-90-R: Die Symptom-Checkliste von Derogatis – Deutsche Version (manual). Göttingen, Beltz Test, 1995.
25.
Znoj H: Der Berner Verbitterungsfragebogen (unpublished questionnaire). Berne, 2002.
26.
Maercker A, Schützwohl M: Erfassung von psychischen Belastungsfolgen: die Impact of Event Skala – revidierte Version (IES-R). Diagnostica 1998;44:130–141.
27.
SPSS Inc: SPSS for Windows (Version 10.0). Chicago, SPSS, 2000.
28.
Paykel ES: Life stress and psychiatric disorder: applications of the clinical approach; in Dohrenwend BS, Dohrenwend BP (ed): Life events: their nature and effects. New York, Wiley & Sons, 1974, pp. 135–150.
29.
Paykel ES: The evolution of life events research in psychiatry. J Affect Disord 2001;62:141–149.
30.
Kendler KS, Karkowski LM, Prescott CA: Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 1999;156:837–848.
31.
Franko DL, Striegel-Moore RH, Brown KM, Barton BA, McMahon RP, Schreiber GB, Crawford PB, Daniels SR: Expanding our understanding of the relationship between negative life events and depressive symptoms in black and white adolescent girls. Psychol Med 2004;34:1319–1330.
32.
Patton GC, Coffey C, Posterino M, Carlin JB, Bowes G: Life events and early onset depression: cause or consequence? Psychol Med 2003;33:1203–1210.
33.
Pasquini M, Picardi A, Biondi M, Gaetano P, Morosini P: Relevance of anger and irritability in outpatients with major depressive disorder. Psychopathology 2004;37:155–160.
34.
Benazzi F: Major depressive disorder with anger: a bipolar spectrum disorder? Psychother Psychosom 2003;72:300–306.
35.
Winkler D, Pjerk E, Kindler J, Heiden A, Kasper S: Validation of a simplified definition of anger attacks. Psychother Psychosom 2006;75:103–106.
36.
Winkler D, Pjerk E, Kindler J, Kasper S: Anger attacks in depression: evidence for a male depressive syndrome. Psychother Psychosom 2005;74:303–307.
37.
Bech P, Hansen HV, Kessing LV: The internalising and externalising dimensions of affective symptoms in depressed (unipolar) and bipolar patients. Psychother Psychosom 2007;75:362–369.
38.
Benazzi F: Is there continuity between bipolar and depressive disorders? Psychother Psychosom 2007;76:70–76.
39.
Sonino N, Fava GA: Rehabilitation in endocrine patients. Psychother Psychosom 2007;76:319–324.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.